Flicker cone function in normal and day blind sheep: a large animal model for human achromatopsia caused by CNGA3 mutation

Gene Therapy for Blindness

(2013) José-Alain Sahel et al.   Annual Review of Neuroscience

Auditory event-related signals in mouse ERG recordings

(2013) Naoyuki Tanimoto et al.   DOCUMENTA OPHTHALMOLOGICA

AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-Achromatopsia

(2012) Ji-jing Pang et al.   PLoS One

Using electroretinograms to assess flicker fusion frequency in domestic hens Gallus gallus domesticus

(2012) Thomas J. Lisney et al.   VISION RESEARCH

Clinical, electroretinographic and histomorphometric evaluation of the retina in sheep with natural scrapie

(2011) Alain Regnier et al.   BMC Veterinary Research

An ancient autosomal haplotype bearing a rare achromatopsia-causing founder mutation is shared among Arab Muslims and Oriental Jews

(2010) Lina Zelinger et al.   HUMAN GENETICS

Restoration of Cone Vision in the CNGA3−/− Mouse Model of Congenital Complete Lack of Cone Photoreceptor Function

(2010) Stylianos Michalakis et al.   MOLECULAR THERAPY

Electroretinography in the western gray kangaroo (Macropus fuliginosus)

(2010) Amber L. Labelle et al.   VETERINARY OPHTHALMOLOGY

Homozygosity Mapping Reveals PDE6C Mutations in Patients with Early-Onset Cone Photoreceptor Disorders

(2009) Alberta A.H.J. Thiadens et al.   AMERICAN JOURNAL OF HUMAN GENETICS

A mutation in gene CNGA3 is associated with day blindness in sheep

(2009) Shay Reicher et al.   GENOMICS

Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism

(2009) X.-Q. Ding et al.   HUMAN MOLECULAR GENETICS

A novel day blindness in sheep: Epidemiological, behavioural, electrophysiological and histopathological studies

(2009) Merav H. Shamir et al.   VETERINARY JOURNAL

Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

(2008) William W. Hauswirth et al.   HUMAN GENE THERAPY